期刊文献+

pH依赖-时滞型5-FU微丸大鼠结肠定位释药研究 被引量:1

Colon-specific drug release from pH-and time-based pellets of 5-fluorouracil in rats
原文传递
导出
摘要 目的验证pH依赖-时滞型5-氟尿嘧啶(5-FU)微丸结肠定位释放效果。方法大鼠灌胃pH依赖-时滞型5-FU微丸,于不同时间取出大鼠消化道不同部位的微丸,通过扫描电镜观察微丸表面形态,采用UV法测定微丸中5-FU的含量,采用HPLC法测定大鼠结肠内容物中5-FU的含量,考察微丸在消化道内不同部位、不同时间的释药性。结果大鼠口服pH依赖-时滞型5-FU微丸后,在进入盲肠之前,从上消化道中解剖得到的微丸含量均大于95%;5~16h在结肠内容物中可检测到5-FU,其含量最高可达到给药剂量的84.26%。结论 pH依赖-时滞型包衣微丸提高了结肠局部的药物浓度,实现了5-FU口服结肠定位的效果。 Objective To evaluate colon-specific release properties of pH-and time-based pellets of 5-fluorouracil(5-FU)in vivo.Methods pH-and time-based colon-specific 5-FU pellets were administered to rats by gavage.The rats were sacrificed at different times,and the pellets in different regions of the gastrointestinal tract were collected.Then the morphology of pellets was observed by scanning electron microscopy,and contents of 5-FU in the pellets and the colonic content were determined by UV and HPLC,respectively.The release characteristics of pellets in different regions of the gastrointestinal tract at different times were evaluated.Results The content of 5-FU was over 95% in pellets collected in the upper gastrointestinal tract before arriving at the cecum.Content of 5-FU could be detected in the colonic content between 5 h and 16 h,and was up to 84.26% of the total dosage.Conclusion Drug concentration of pH-and time-based 5-FU colon-specific pellets is enhanced in the colon,and the colon-specific effect is exerted by oral administration.
出处 《山东大学学报(医学版)》 CAS 北大核心 2010年第12期46-50,共5页 Journal of Shandong University:Health Sciences
关键词 5-氟尿嘧啶 pH依赖-时滞型微丸 结肠定位给药系统 5-Fluorouracil; pH-and time-based pellets; Colon-specific drug delivery system;
  • 相关文献

参考文献7

二级参考文献49

  • 1Tozaki H, Odoriba T, Okada N, et al. Chitosan capsules for colonspecific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats [J]. J Control Release, 2002, 82(1): 51.
  • 2Reddy SM, Sinha VR, Reddy DS. Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptied drugs [J].Drugs of Today, 1999, 35(7): 537.
  • 3Shantha KL, Ravichandran P, Rao PK. Azo polymeric hydrogels for colon targeted drug delivery[J]. Biomaterials, 1995, 16(17): 1313.
  • 4Chavan MS, Sant VP, Nagarsenker MS. Azo-containing urethane analogues for colonic drug delivery: synthesis, characterization and in-vitro evaluation[J]. J Pham Pharmacol, 2001, 53(6): 895.
  • 5Vandamme TF, Lenourry A, Charrueau C, et al. The use of polysaccharides to target drugs to the colon[J]. Carbohydrate Polymers, 2002,48(3): 219.
  • 6Wong D, Larrabee S, Clifford K, et al. USP Dissolution Apparatus 111(reciprocating cylinder) for screening of guar-based colonic delivery formulations[J]. J Control Release, 1997, 47(2): 173.
  • 7Rama PYV, Krishnaiah YSR, Satyanarayana S. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery[J]. J Control Release, 1998, 51 (2-3): 281.
  • 8Yang L, Chu JS, Fix JA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation[J]. Int J Pharm, 2002, 235(1): 1.
  • 9Brondsted H, Andersen C, Hovgaard L. Crosslinked dextran-a new capsule material for colon targeting of drugs[J]. J Control Release,1998, 53(1): 7.
  • 10Molly K, Vande Woestyne M, Verstracate W. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem[J]. Appl Microbid Biotechnol, 1993, 39(2):254.

共引文献29

同被引文献18

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部